Winton Group LTD Matinas Bio Pharma Holdings, Inc. Transaction History

Winton Group LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$0.92 - $1.22 $29,164 - $38,675	-31,701 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$0.67 - $1.51 $13,471 - $30,360	-20,106 Reduced 38.81%	31,701 $41,000
Q2 2021 Aug 10, 2021	SELL	$0.75 - $1.1 $27,411 - $40,203	-36,549 Reduced 41.37%	51,807 $40,000
Q1 2021 Jul 21, 2021	SELL	$0.96 - $1.74 $6,980 - $12,651	-7,271 Reduced 7.6%	88,356 $93,000
Q4 2020 Feb 12, 2021	SELL	$0.76 - $1.47 $107,870 - $208,644	-141,935 Reduced 59.75%	95,627 $130,000
Q3 2020 Oct 30, 2020	BUY	$0.67 - $0.96 $91,874 - $131,640	137,126 Added 136.53%	237,562 $182,000
Q2 2020 Aug 05, 2020	SELL	$0.52 - $0.92 $4,079 - $7,217	-7,845 Reduced 7.25%	100,436 $78,000
Q1 2020 May 11, 2020	SELL	$0.6 - $2.31 $34,198 - $131,663	-56,997 Reduced 34.49%	108,281 $65,000
Q4 2019 Feb 13, 2020	SELL	$0.63 - $2.27 $5,319 - $19,167	-8,444 Reduced 4.86%	165,278 $375,000
Q3 2019 Nov 08, 2019	BUY	$0.59 - $0.9 $102,495 - $156,349	173,722 New	173,722 $110,000

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.